|
| 36926984 | Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types. | | 2023 |
| 37061918 | Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. | Cell Rep | 2023 |
| 34678491 | Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men. | Contemporary Clinical Trials | 2022 |
| 36182824 | Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach. | eBioMedicine | 2022 |
| 36278321 | Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling. | Bioanalysis | 2022 |
| 36208978 | Immunogenicity of rVSVοG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials. | Vaccine | 2022 |
| 36146524 | Lessons Learned from the Development and Roll-Out of the rVSVοG-ZEBOV-GP Vaccine to Inform Marburg Virus and Vaccines. | Vaccines | 2022 |
| 35809371 | Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial. | eBioMedicine | 2022 |
| 33719915 | High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. | Emerg Microbes Infect | 2021 |
| 35544244 | Estimation of the correlates of protection of the rVSVοG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials. | Lancet Microbe, The | 2021 |
| 33782211 | Effects of Gamma Irradiation of Human Serum Samples from rVSVοG-ZEBOV-GP (V920) Ebola Virus Vaccine Recipients on Plaque-Reduction Neutralization Assays. | American Journal of Tropical Medicine and Hygiene | 2021 |
| 33668698 | Development of Pandemic Vaccines: ERVEBO Case Study. | Vaccines | 2021 |
| 32499064 | Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis. | Vaccine | 2020 |
| 33352786 | Environmental Risk Assessment for rVSVοG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease. | Vaccines | 2020 |
| 33078980 | A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model. | Journal of Immunotoxicology | 2020 |
| 31384731 | rVSVοG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment. | Vaccine X | 2019 |
| 30427741 | Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. | Human Vaccines and Immunotherapeutics | 2019 |
| 31162004 | Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine. | American Journal of Tropical Medicine and Hygiene | 2019 |
| 28298602 | A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge. | J Virol | 2017 |
| 28918539 | Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak. | Current Topics in Microbiology and Immunology | 2017 |
| 28647166 | Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic. | Vaccine | 2017 |
| 28502771 | Metabolic Phenotypes of Response to Vaccination in Humans. | Cell | 2017 |
| 27797961 | A replication-defective human cytomegalovirus vaccine for prevention of congenital infection. | Sci Transl Med | 2016 |
| 26555351 | A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens. | Vaccine | 2016 |
| 26491897 | Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. | mAbs | 2016 |
| 26579128 | Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination. | Frontiers in Immunology | 2015 |
| 26458804 | Preclinical and clinical development of a dengue recombinant subunit vaccine. | Vaccine | 2015 |
| 23497415 | Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors. | Journal of Translational Medicine | 2013 |
| 23824772 | Caspase activation as a versatile assay platform for detection of cytotoxic bacterial toxins. | Journal of Clinical Microbiology | 2013 |
| 23107592 | Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. | Vaccine | 2012 |
| 21695251 | Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. | PLoS ONE | 2011 |
| 21358627 | Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. | Nature Medicine | 2011 |
| 20854108 | Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. | AIDS Research and Human Retroviruses | 2011 |
| 21570062 | Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists. | Cellular Immunology | 2011 |
| 20381019 | Synthesis and immunological activities of novel agonists of toll-like receptor 9. | Cellular Immunology | 2010 |
| 21203546 | Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. | PLoS One | 2010 |
| 20937317 | Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans. | Vaccine | 2010 |
| 20042509 | Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge. | Journal of Virology | 2010 |
| 19929694 | Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens. | J Infect Dis | 2010 |
| 19108693 | Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. | AIDS Research and Human Retroviruses | 2009 |
| 19620962 | Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. | Nat Med | 2009 |
| 19620961 | Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. | Nature Medicine | 2009 |
| 18433307 | Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. | Clin Infect Dis | 2008 |
| 19012957 | HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. | Lancet, The | 2008 |
| 18524823 | DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles. | Journal of Virology | 2008 |
| 17310936 | Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. | Journal of acquired immune deficiency syndromes (1999) | 2007 |
| 17263637 | Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. | AIDS Research and Human Retroviruses | 2007 |
| 17263635 | Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. | AIDS Research and Human Retroviruses | 2007 |
| 16760794 | Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. | J Acquir Immune Defic Syndr | 2006 |
| 17147493 | A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects. | AIDS Research and Human Retroviruses | 2006 |